VEGFA and neoplasm: The interaction between CD40 and its ligand CD40L can cause tumor growth inhibition due to immunologic mechanisms and apoptosis induction; alternatively, it may promote tumor growth through the action of cytokines and growth factors, such as interleukin 6 and vascular endothelial growth factor (3).